Health
Spironolactone may be safe to treat female pattern hair loss in breast cancer survivors – News-Medical.Net
Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University Department of Dermatology.
Reviewed by Emily Henderson, B.Sc.Sep 9 2020
Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University (GW) Department of Dermatology. The study, published in the Journal of the American Academy of Dermatology, found that the drug may be safe for use in treating breast cancer survivors with female pattern hair loss.
Androgens contribute significantly to the pathogenesis of female patterned hair loss. The…
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM